This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Bausch + Lomb Ireland Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Gregory Morandi: Innovator in Ocular Treatments
Introduction
Gregory Morandi is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of ocular treatments, particularly through his innovative patent. His work focuses on improving the quality of life for individuals suffering from ocular surface pain and related conditions.
Latest Patents
Morandi holds a patent for "Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and formulations thereof." This patent provides polymorphs and formulations of the compound, which is aimed at treating ocular surface pain. Additionally, it outlines methods for addressing dry eye disease and ocular hyperemia through the administration of this compound.
Career Highlights
Gregory Morandi is associated with Bausch + Lomb Ireland Limited, a company renowned for its commitment to eye health. His work at the company has been instrumental in advancing ocular treatment options. With a focus on innovative solutions, Morandi continues to contribute to the field of ophthalmology.
Collaborations
Some of Morandi's notable coworkers include Joseph Paul Bullock and Chinmay Maheshwari. Their collaborative efforts have further enhanced the research and development of ocular treatments.
Conclusion
Gregory Morandi's contributions to ocular treatments through his patent demonstrate his commitment to improving patient care. His innovative work continues to pave the way for advancements in the field of ophthalmology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile